Home>
US Stocks>
Bionexus Gene Lab Corp

Bionexus Gene Lab Corp share price today

(BGLC)

Bionexus Gene Lab Corp share price is $0.29 & ₹24.55 as on 7 Dec 2024, 2.30 'hrs' IST

$0.29

▲

-0.01

(-3%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Bionexus Gene Lab Corp share price in Dollar and Rupees. Guide to invest in Bionexus Gene Lab Corp from India. Also see the sentimental analysis on Indian investors investing in Bionexus Gene Lab Corp. Get details on the Indian mutual funds that are investing in Bionexus Gene Lab Corp. Get Analyst recommendations and forecasts along with all the Bionexus Gene Lab Corp's financials.

Bionexus Gene Lab Corp share price movements

$0.29
$0.32
$0.29
0.0%
Downside
Day's Volatility :9.38%
Upside
9.38%
$0.23
$3.39
$0.29
20.24%
Downside
52 Weeks Volatility :93.18%
Upside
91.45%

Bionexus Gene Lab Corp Returns

Period	Bionexus Gene Lab Corp	Index (Russel 2000)
3 Months	-21.41%	0.0%
6 Months	-43.4%	0.0%
1 Year	-61.04%	0.0%
3 Years	-98.77%	-19.7%

Bionexus Gene Lab Corp Key Statistics

in dollars & INR

Previous Close	$0.3
Open	$0.31
Today's High	$0.32
Today's Low	$0.29
Market Capitalization	$5.4M
Today's Volume	$222.0K
52 Week High	$3.39
52 Week Low	$0.2313
Revenue TTM	$9.2M
EBITDA	$-1.5M
Earnings Per Share (EPS)	$-0.06
Profit Margin	-24.01%
Quarterly Earnings Growth YOY	-0.95%
Return On Equity TTM	-28.44%

How to invest in Bionexus Gene Lab Corp from India?

It is very easy for Indian residents to invest directly in Bionexus Gene Lab Corp from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bionexus Gene Lab Corp stock in both rupees (INR) and dollars (USD). Search for Bionexus Gene Lab Corp or BGLC on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bionexus Gene Lab Corp or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bionexus Gene Lab Corp shares which would translate to 2.919 fractional shares of Bionexus Gene Lab Corp as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Bionexus Gene Lab Corp

68%

Period: Sep 7, 2024 to Dec 6, 2024. Change in 30 Days versus previous period

Search volume for Bionexus Gene Lab Corp on INDmoney from India has grown in the last 30 days as on Dec 7, 2024. 68% more investors are searching Bionexus Gene Lab Corp in the last 30 days versus the previous period.

Analyst Recommendation on Bionexus Gene Lab Corp

Insights on Bionexus Gene Lab Corp

Increasing Revenue
Revenue is up for the last 2 quarters, 1.97M → 2.63M (in $), with an average increase of 24.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 199.10K → -1.34M (in $), with an average decrease of 775.7% per quarter
Vs SHW
In the last 1 year, Sherwin-williams Company, The has given 34.4% return, outperforming this stock by 90.9%

Bionexus Gene Lab Corp Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$212.3K	-
Net Income	$26.5K	-
Net Profit Margin	12.46%	-

	FY19	Y/Y Change
Revenue	$127.0K	↓ 40.21%
Net Income	$-246.5K	↓ 1031.69%
Net Profit Margin	-194.14%	↓ 206.6%

	FY20	Y/Y Change
Revenue	$11.4M	↑ 8872.03%
Net Income	$1.1M	↓ 543.91%
Net Profit Margin	9.61%	↑ 203.75%

	FY21	Y/Y Change
Revenue	$13.4M	↑ 17.31%
Net Income	$751.6K	↓ 31.31%
Net Profit Margin	5.62%	↓ 3.99%

	FY22	Y/Y Change
Revenue	$10.9M	↓ 18.21%
Net Income	$-356.0K	↓ 147.36%
Net Profit Margin	-3.26%	↓ 8.88%

	FY23	Y/Y Change
Revenue	$9.8M	↓ 10.6%
Net Income	$-2.6M	↑ 638.57%
Net Profit Margin	-26.91%	↓ 23.65%

	Q2 FY23	Q/Q Change
Revenue	$2.6M	↑ 7.98%
Net Income	$-259.3K	↑ 275.37%
Net Profit Margin	-10.1%	↓ 7.19%

	Q3 FY23	Q/Q Change
Revenue	$2.6M	↓ 0.51%
Net Income	$-2.6M	↑ 906.03%
Net Profit Margin	-102.13%	↓ 92.03%

	Q4 FY23	Q/Q Change
Revenue	$2.3M	↓ 10.99%
Net Income	$307.4K	↓ 111.79%
Net Profit Margin	13.52%	↑ 115.65%

	Q1 FY24	Q/Q Change
Revenue	$2.4M	↑ 4.79%
Net Income	$-103.8K	↓ 133.75%
Net Profit Margin	-4.36%	↓ 17.88%

	Q2 FY24	Q/Q Change
Revenue	$2.0M	↓ 17.1%
Net Income	$199.1K	↓ 291.89%
Net Profit Margin	10.08%	↑ 14.44%

	Q3 FY24	Q/Q Change
Revenue	$2.6M	↑ 33.21%
Net Income	$-1.3M	↓ 775.71%
Net Profit Margin	-51.15%	↓ 61.23%

	FY18	Y/Y Change
Total Assets	$1.7M	-
Total Liabilities	$130.3K	-

	FY19	Y/Y Change
Total Assets	$1.2M	↓ 25.48%
Total Liabilities	$108.9K	↓ 16.45%

	FY20	Y/Y Change
Total Assets	$10.1M	↑ 721.56%
Total Liabilities	$3.5M	↑ 3071.74%

	FY21	Y/Y Change
Total Assets	$9.6M	↓ 5.35%
Total Liabilities	$2.4M	↓ 30.65%

	FY22	Y/Y Change
Total Assets	$8.7M	↓ 8.71%
Total Liabilities	$2.1M	↓ 13.34%

	FY23	Y/Y Change
Total Assets	$11.4M	↑ 30.43%
Total Liabilities	$1.7M	↓ 16.06%

	Q2 FY23	Q/Q Change
Total Assets	$7.9M	↓ 3.51%
Total Liabilities	$1.9M	↑ 18.74%

	Q3 FY23	Q/Q Change
Total Assets	$11.5M	↑ 45.15%
Total Liabilities	$1.8M	↓ 8.13%

	Q4 FY23	Q/Q Change
Total Assets	$11.4M	↓ 0.57%
Total Liabilities	$1.7M	↓ 2.02%

	Q1 FY24	Q/Q Change
Total Assets	$11.2M	↓ 2.09%
Total Liabilities	$1.8M	↑ 4.33%

	Q2 FY24	Q/Q Change
Total Assets	$11.1M	↓ 0.19%
Total Liabilities	$1.6M	↓ 12.29%

	Q3 FY24	Q/Q Change
Total Assets	$11.0M	↓ 1.3%
Total Liabilities	$1.6M	↑ 0.81%

	FY18	Y/Y Change
Operating Cash Flow	$-274.1K	↓ 176.73%
Investing Cash Flow	$-51.7K	↓ 99.03%
Financing Cash Flow	$742.9K	↓ 87.15%

	FY19	Y/Y Change
Operating Cash Flow	$-217.3K	↓ 20.73%
Investing Cash Flow	$-12.8K	↓ 75.21%
Financing Cash Flow	$-180.8K	↓ 124.34%

	FY20	Y/Y Change
Operating Cash Flow	$552.7K	↓ 354.37%
Investing Cash Flow	$1.3M	↓ 10398.74%
Financing Cash Flow	$-4.9K	↓ 97.26%

	FY21	Y/Y Change
Operating Cash Flow	$9.2K	↓ 98.34%
Investing Cash Flow	$-490.6K	↓ 137.16%
Financing Cash Flow	$-28.2K	↑ 470.49%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-22.0K	↓ 81.37%
Investing Cash Flow	$-3.1K	↓ 39.52%
Financing Cash Flow	$-4.2K	↓ 51.54%

Bionexus Gene Lab Corp Technicals Summary

Sell

Neutral

Buy

Bionexus Gene Lab Corp is currently in a neutral trading position according to technical analysis indicators.

Bionexus Gene Lab Corp Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Bionexus Gene Lab Corp	-15.97%	-43.4%	-61.04%	-98.77%	-98.77%
Air Products & Chemicals Inc.	4.97%	14.05%	22.3%	8.9%	39.49%
Linde Plc	-3.04%	3.84%	11.79%	34.63%	118.47%
Dupont De Nemours Inc	-3.07%	2.33%	15.31%	4.45%	28.04%
Sherwin-williams Company, The	1.18%	31.43%	32.92%	12.57%	100.45%
Ecolab Inc.	1.34%	3.86%	29.08%	6.75%	33.9%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Bionexus Gene Lab Corp	NA	NA	NA	0.0	-0.28	-0.1	NA	0.55
Air Products & Chemicals Inc.	19.01	19.01	11.95	12.33	0.23	0.05	0.02	76.53
Linde Plc	34.85	34.85	2.51	15.47	0.16	0.07	0.01	82.27
Dupont De Nemours Inc	63.86	63.86	0.45	3.9	0.02	0.03	0.02	57.94
Sherwin-williams Company, The	39.07	39.07	3.58	11.35	0.64	0.1	0.01	16.59
Ecolab Inc.	34.73	34.73	2.49	6.65	0.25	0.07	0.01	23.46

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Bionexus Gene Lab Corp	NA	$5.4M	-98.77%	NA	-24.01%
Air Products & Chemicals Inc.	Buy	$72.8B	39.49%	19.01	31.64%
Linde Plc	Buy	$218.8B	118.47%	34.85	19.33%
Dupont De Nemours Inc	Buy	$34.2B	28.04%	63.86	6.55%
Sherwin-williams Company, The	Buy	$98.7B	100.45%	39.07	11.09%
Ecolab Inc.	Hold	$70.2B	33.9%	34.73	13.05%

About Bionexus Gene Lab Corp

Organization	Bionexus Gene Lab Corp
Employees	30
CEO	Mr. Su-Leng Tan
Industry	Commercial Services

Management People of Bionexus Gene Lab Corp

Name	Title
Mr. Su-Leng Tan	CEO, Acting CFO, Secretary & Director
Mr. Kwan Wah Chan	Marketing Manager
Mr. Too Kam Tham	Managing Director

Important FAQs about investing in Bionexus Gene Lab Corp from India :

What is Bionexus Gene Lab Corp share price today?

Bionexus Gene Lab Corp (BGLC) share price today is $0.29.

Can Indians buy Bionexus Gene Lab Corp shares?

Yes, Indians can invest in the Bionexus Gene Lab Corp (BGLC) from India.

With INDmoney, you can buy Bionexus Gene Lab Corp at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Bionexus Gene Lab Corp at zero transaction cost.

How can I buy Bionexus Gene Lab Corp shares from India?

It is very easy to buy Bionexus Gene Lab Corp from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bionexus Gene Lab Corp be purchased?

Yes, you can buy fractional shares of Bionexus Gene Lab Corp with INDmoney app.

What are the documents required to start investing in Bionexus Gene Lab Corp stocks?

To start investing in Bionexus Gene Lab Corp, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.